Arthur Greenberg, Joseph G Verbalis, Alpesh N Amin, Volker R Burst, Joseph A Chiodo, Jun R Chiong, Joseph F Dasta, Keith E Friend, Paul J Hauptman, Alessandro Peri, Samuel H Sigal
Current management practices for hyponatremia (HN) are incompletely understood. The HN Registry has recorded diagnostic measures, utilization, efficacy, and outcomes of therapy for eu- or hypervolemic HN. To better understand current practices, we analyzed data from 3087 adjudicated adult patients in the registry with serum sodium concentration of 130 mEq/l or less from 225 sites in the United States and European Union. Common initial monotherapy treatments were fluid restriction (35%), administration of isotonic (15%) or hypertonic saline (2%), and tolvaptan (5%); 17% received no active agent...
July 2015: Kidney International